Comparison of pravastatin with crystalline nicotinic acid monotherapy in treatment of combined hyperlipidemia.
Pravastatin treatment of combined hyperlipidemia lowers low-density lipoprotein effectively; nicotinic acid lowers remnant cholesterol and raises high-density lipoprotein. A combination of these 2 drugs may be indicated for optimal treatment of lipoprotein abnormalities in combined hyperlipidemia.
Mostaza
J M
JM
Veterans Affairs Medical Center, Department of Clinical Nutrition, Center for Human Nutrition of the University of Texas Southwestern Medical Center at Dallas, 75235-9052, USA.
Schulz
I
I
Vega
G L
GL
Grundy
S M
SM
D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D018592:Cross-Over Studies; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D008875:Middle Aged; D009525:Niacin / Q000627:therapeutic use*; D017035:Pravastatin / Q000627:therapeutic use*; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D014280:Triglycerides; D009525:Niacin; D002784:Cholesterol; D017035:Pravastatin